MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617030809 A) filed by University Of Copenhagen; and Tetrakit Technologies Aps on March 14, 2026, for Psma Theranostic Compounds Assembled With Tetrazine-Trans-Cyclooctene Ligation.
Inventors include Herth, Matthias Manfred; Kjr, Andreas; Battisti, Umberto Maria; Shalgunov, Vladimir; Poulie, Christian Bernard Matthijs; Mller, Marius; and Jensen, Andreas.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure regards PSMA targeting urea-based ligands comprising a PSMA targeting moiety, a linker, and a pyridazine moiety. The PSMA targeting urea- based ligands disclosed are suitable for use as radiopharmaceuticals, either as imaging agents, such as diagnostic agents, or for the treatment of prostate cancer or as theranostic agents.
Disclaimer: Curated by HT Syndication.
